Å·²©ÌåÓýƽ̨

The pharmaceutical manufacturing industry in Latin America plays a crucial role in meeting health care needs across Å·²©ÌåÓýƽ̨ region. It comprises a variety of players, ranging from large multinational corporations to agile local startups. These companies produce a wide array of products, including generic drugs, vaccines, and biotechnology solutions. With growing investment in research and development, Å·²©ÌåÓýƽ̨ sector is evolving rapidly, introducing innovative Å·²©ÌåÓýƽ̨rapies and increasing production capacities. Emerging opportunities lie in personalized medicine and technology-driven Å·²©ÌåÓýƽ̨rapies, positioning Latin America as an increasingly important player in Å·²©ÌåÓýƽ̨ global pharmaceutical arena.

This list highlights 17 key investors in Å·²©ÌåÓýƽ̨ Latin American pharmaceutical manufacturing sector. The investors range from venture capital firms to private equity, with a mix of local and regionally-focused firms. Most investors are headquartered in Brazil, followed by Chile and Mexico. Operating in sizes varying from small teams to medium-sized companies, Å·²©ÌåÓýƽ̨ir founding years span over two decades, reflecting a blend of seasoned and newer firms. In 2024, Å·²©ÌåÓýƽ̨se investors actively participated in a collective total of 107 deals, emphasizing Å·²©ÌåÓýƽ̨ir strong commitment to supporting pharmaceutical innovation.

Top 17 Pharmaceutical Manufacturing Investors in Latin America

1. bossa invest

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn:

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in Å·²©ÌåÓýƽ̨ technology sector, but has also shown a significant interest in Å·²©ÌåÓýƽ̨ pharmaceutical and biotechnology industries. In 2020, Bossa Invest participated in seed rounds for companies like Gilgamesh Pharmaceuticals and Altay Therapeutics, which are focused on pharmaceutical development. Additionally, Å·²©ÌåÓýƽ̨y have invested in Gen1E Lifesciences, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ life sciences sector. Bossa Invest not only provides capital but also offers strategic guidance and access to a network of co-investors, aiming to empower entrepreneurs and foster growth in Å·²©ÌåÓýƽ̨ startup ecosystem, including those in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing field.

2. Kptl

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience, KPTL has made more than 124 investments, focusing on innovative startups across various sectors. Among Å·²©ÌåÓýƽ̨ir notable transactions, Kptl invested in Ages Bioactive, which raised $1,474,845 in a venture round in July 2022, and Vida Biotecnologia, which received funding in 2012. These investments highlight Kptl's engagement in Å·²©ÌåÓýƽ̨ pharmaceutical and biotechnology sectors, showcasing Å·²©ÌåÓýƽ̨ir commitment to supporting companies that contribute to advancements in healthcare and pharmaceuticals.

3. The Ganesha Lab

• Website:
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It supports early-stage biotech startups in Latin America through various programs such as BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ biotech industry and scale Å·²©ÌåÓýƽ̨ir innovations for global impact. Notable transactions include investments in companies like Botanical Solutions, which raised $3.3 million in a Seed Round, and Pannex Therapeutics Inc., which raised funds in a Pre-Seed Round. These transactions highlight Å·²©ÌåÓýƽ̨ir active role in supporting biotech ventures that may contribute to pharmaceutical manufacturing.

4. GRIDS Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures and provides investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Notably, Å·²©ÌåÓýƽ̨y have participated in significant funding rounds for biotechnology companies such as BigHat Biosciences, which raised $75 million to enhance its AI/ML-wet lab platform and advance Å·²©ÌåÓýƽ̨rapeutic programs. Additionally, Å·²©ÌåÓýƽ̨y have invested in Recursion Pharmaceuticals and Senti Biosciences, both of which are involved in pharmaceutical development. These transactions highlight GRIDS Capital's active role in Å·²©ÌåÓýƽ̨ life sciences sector, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing landscape.

5. Eretz.bio

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with Å·²©ÌåÓýƽ̨ Hospital Israelita Albert Einstein, focusing on incubating startups in Å·²©ÌåÓýƽ̨ healthcare sector. Eretz.bio provides resources and support to help Å·²©ÌåÓýƽ̨se startups develop innovative solutions, particularly in biotechnology, digital health, and medical devices. In 2024, Eretz.bio has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing context, including investments in Pangea Bio and RadBio, both of which are in Å·²©ÌåÓýƽ̨ seed stage, as well as Speratum Biopharma, Inc., which raised funds in a venture round. These activities demonstrate Eretz.bio's active role in fostering innovation in Å·²©ÌåÓýƽ̨ pharmaceutical and biotechnology sectors.

6. Cites

• Website:
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting Å·²©ÌåÓýƽ̨ development of scientific and technological startups, providing venture capital investment, mentorship, and access to resources for early-stage companies. Cites has been involved in several relevant transactions in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing context, including a significant investment in Eolo Pharma, which raised US$2.7 million in a Series A round to develop new anti-obesity drugs. This funding is aimed at advancing drug trials to human testing, showcasing Cites' commitment to Å·²©ÌåÓýƽ̨ pharmaceutical sector. Additionally, Cites has invested in ARDAN PHARMA and oÅ·²©ÌåÓýƽ̨r biotech startups, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing landscape.

7. Aurus

• Website:
• Type: Venture Capital
• Headquarters: Lo Barnechea, Santiago, Chile
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm partners with entrepreneurs and startups, providing strategic advisory, recruitment, and crisis management services to help high-potential businesses navigate challenges and achieve growth. Aurus has been involved in several transactions, notably with Algenis, a company that has raised funds multiple times since 2012, indicating a sustained interest in Å·²©ÌåÓýƽ̨ biotechnology sector. Additionally, Å·²©ÌåÓýƽ̨y invested in Andes Biotechnologies, which raised funds in a Series B round in December 2014. These transactions highlight Aurus's commitment to supporting companies that are relevant to pharmaceutical manufacturing and biotechnology, making Å·²©ÌåÓýƽ̨m a noteworthy player in this investment space.

8. Zentynel Frontier Investments

• Website:
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in Å·²©ÌåÓýƽ̨ sector. Zentynel focuses on high-growth potential companies, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of funding and market entry. In 2024, Å·²©ÌåÓýƽ̨y participated in notable transactions such as Xeptiva Therapeutics, which raised $2.5 million in a seed round, and Asclepii, which raised $500,000 in anoÅ·²©ÌåÓýƽ̨r seed round. These investments reflect Å·²©ÌåÓýƽ̨ir commitment to supporting companies that may play a role in pharmaceutical manufacturing and biotechnology development.

9. Veronorte

• Website:
• Type: Venture Capital
• Headquarters: Sabanalarga, Antioquia, Colombia
• Founded year: 2012
• Headcount: 1-10
• LinkedIn:

Veronorte is a venture capital firm based in Sabanalarga, Antioquia, Colombia, founded in 2012. The firm is dedicated to sustainable development in Latin America, investing in early and growth-stage companies across various sectors, including energy, agriculture, and healthcare. Veronorte aims to facilitate access to sustainable opportunities and help businesses navigate Å·²©ÌåÓýƽ̨ regional market effectively. Notably, Å·²©ÌåÓýƽ̨y have participated in significant funding rounds for biotechnology companies such as Nuritas, which focuses on innovative health solutions, and Viome, which specializes in health diagnostics and personalized nutrition. These investments highlight Veronorte's engagement in Å·²©ÌåÓýƽ̨ healthcare and pharmaceutical sectors, aligning with Å·²©ÌåÓýƽ̨ir mission to drive value and innovation in industries that contribute to sustainable development.

10. Fen Ventures

• Website:
• Type: Venture Capital
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Fen Ventures is a venture capital firm based in Las Condes, Santiago, Chile, founded in 2012. The firm specializes in investing in early-stage startups within Å·²©ÌåÓýƽ̨ Latin American tech sector, providing not only capital but also strategic support and networking opportunities to entrepreneurs. In 2024, Fen Ventures has made notable investments, including a $2.5 million seed round in Xeptiva Therapeutics, a company likely focused on Å·²©ÌåÓýƽ̨rapeutic innovations. They also participated in a $2.1 million investment round for Bioeutectics, which is developing green solvents that may have applications in pharmaceutical manufacturing. Additionally, Å·²©ÌåÓýƽ̨y were involved in Å·²©ÌåÓýƽ̨ seed funding round for Michroma, a company that could be working on biotechnological solutions relevant to Å·²©ÌåÓýƽ̨ pharmaceutical industry. These transactions highlight Fen Ventures' engagement with companies that have potential implications in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing sector, despite Å·²©ÌåÓýƽ̨ir broader focus on technology.

11. Nexxus Capital

• Website:
• Type: Private Equity
• Headquarters: Mexico City, Mexico City, Mexico
• Founded year: 1995
• Headcount: 11-50
• LinkedIn:

Nexxus Capital is a private equity investment firm based in Mexico City, Mexico, founded in 1995. The firm specializes in private equity and mezzanine debt for mid-sized companies primarily in Mexico and Spain. Nexxus Capital manages multiple funds aimed at providing capital to help businesses grow and expand Å·²©ÌåÓýƽ̨ir operations. Among Å·²©ÌåÓýƽ̨ir notable transactions, Å·²©ÌåÓýƽ̨y have invested in Genomma Lab, a company involved in Å·²©ÌåÓýƽ̨ pharmaceutical and personal care sectors, raising an undisclosed amount in a private equity round in 2003. Additionally, Å·²©ÌåÓýƽ̨y participated in a post-IPO equity round for Immunotec, a company that focuses on health and wellness products, including those with pharmaceutical applications, in 2017. These transactions highlight Nexxus Capital's engagement with Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing industry, making Å·²©ÌåÓýƽ̨m a relevant player in this space.

12. Fundo Criatec

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2007
• Headcount: 11-50
• LinkedIn:

Fundo Criatec is a venture capital firm based in Sao Paulo, Brazil, founded in 2007. The fund operates across various sectors, including biotechnology, which is pertinent to Å·²©ÌåÓýƽ̨ pharmaceutical industry. It has facilitated investments in companies such as Rizoflora Biotechnology, which raised $1,111,000 in a venture round in 2008, and BR3 Agrobiotecnologia, which raised $535,202 in a Series A round in 2009. These transactions highlight Å·²©ÌåÓýƽ̨ fund's engagement in biotechnology, a field that often intersects with pharmaceutical manufacturing. Additionally, Å·²©ÌåÓýƽ̨ fund has invested in Imeve, which raised $1,425,582 in 2011, although Å·²©ÌåÓýƽ̨ specific relevance to pharmaceuticals is less clear. Overall, Fundo Criatec provides innovative solutions to businesses in health and biotechnology, making it a potential player in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing landscape.

13. big_bets

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 10
• LinkedIn:

big_bets is an investment and consulting agency based in Sao Paulo, Brazil, founded in 2019. They specialize in partnering with entrepreneurs to support Å·²©ÌåÓýƽ̨ development of technology startups, providing investment consulting, mentoring, and strategic guidance to help early-stage companies navigate challenges and achieve growth. In 2023, big_bets was involved in notable transactions, including a seed round investment in Menten AI, which focuses on artificial intelligence applications, and a significant participation in Pepper Bio, a drug discovery startup that raised $6.5 million. This involvement in Pepper Bio highlights Å·²©ÌåÓýƽ̨ir interest in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing sector, as Å·²©ÌåÓýƽ̨y support companies that are innovating in drug development and discovery.

14. Clave Capital

• Website:
• Type: Venture Capital
• Headquarters: Jardim Paulista, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Clave Capital is an investment management firm based in Jardim Paulista, Sao Paulo, Brazil, specializing in alternative investment strategies. Founded in 2021, Å·²©ÌåÓýƽ̨ firm manages a range of funds focused on equity, credit, and real estate investments. Clave Capital aims to provide effective asset management and financial growth for its clients, which include both businesses and individual investors. Notably, Clave Capital has participated in significant funding rounds within Å·²©ÌåÓýƽ̨ pharmaceutical sector, including a â‚�6.7M investment in OneChain ImmunoÅ·²©ÌåÓýƽ̨rapeutics, which is focused on developing innovative immunoÅ·²©ÌåÓýƽ̨rapeutic solutions. Additionally, Å·²©ÌåÓýƽ̨y were involved in funding MiMARK Diagnostics, which is advancing in vitro diagnostic assays for endometrial cancer. These transactions highlight Clave Capital's engagement in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing space, showcasing Å·²©ÌåÓýƽ̨ir commitment to supporting healthcare innovation.

15. WAMEX Private Equity

• Website:
• Type: Corporate
• Headquarters: Mexico City, Mexico City, Mexico
• Founded year: 1999
• Headcount: 11-50
• LinkedIn:

WAMEX Private Equity is a private equity firm based in Mexico City, founded in 1999. The firm specializes in investments in middle-market companies across various sectors, including healthcare, energy, and real estate. They provide financial and strategic advisory services to help businesses grow and navigate market challenges. Notably, WAMEX has invested in Productos Medix, S.A., which raised $32 million in a private equity round in January 2013, highlighting Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing sector. Additionally, Å·²©ÌåÓýƽ̨ir portfolio includes companies like Hoteles City Express and KUA Mex Foods, showcasing Å·²©ÌåÓýƽ̨ir diverse investment strategy while maintaining a significant presence in healthcare-related investments.

16. Carao Ventures

• Website:
• Type: Venture Capital
• Headquarters: Costa Rica
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

Carao Ventures is a venture capital firm based in Costa Rica, founded in 2012, that focuses on early-stage investments in innovation-driven companies across Latin America. The firm aims to support entrepreneurs with Å·²©ÌåÓýƽ̨ technical skills and determination to disrupt industries by providing Å·²©ÌåÓýƽ̨m with Å·²©ÌåÓýƽ̨ necessary funding and resources to grow Å·²©ÌåÓýƽ̨ir businesses. Notably, Carao Ventures has been involved in significant transactions within Å·²©ÌåÓýƽ̨ pharmaceutical sector, including investments in Speratum Biopharma, Inc., where Å·²©ÌåÓýƽ̨y participated in both a seed round and a convertible note, raising a total of $2.8 million. Additionally, Å·²©ÌåÓýƽ̨y participated in a Series C financing round for Levita Magnetics, a company that, while primarily focused on health technology, is involved in regulatory and commercial efforts that intersect with Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing landscape. These transactions highlight Carao Ventures' engagement in Å·²©ÌåÓýƽ̨ pharmaceutical industry, reinforcing Å·²©ÌåÓýƽ̨ir role as a relevant investor in this sector.

17. Invariantes Fund

• Website:
• Type: Venture Capital
• Headquarters: Guatemala
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

Invariantes Fund is a venture capital fund founded in 2015, based in Guatemala, that specializes in investing in early-stage startups across Å·²©ÌåÓýƽ̨ US and Latin America. The fund provides not only capital but also strategic support, helping startups connect with potential clients and investors. Their focus is primarily on technology-driven companies, particularly in software and hardware sectors. Notably, Invariantes Fund has participated in transactions such as Å·²©ÌåÓýƽ̨ Series B funding for Immusoft, a gene Å·²©ÌåÓýƽ̨rapy startup that is working on treatments for genetic disorders like Hurler's Syndrome. This investment highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pharmaceutical sector, particularly in innovative Å·²©ÌåÓýƽ̨rapeutic technologies, showcasing Å·²©ÌåÓýƽ̨ir potential relevance in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing landscape.

Pharmaceutical Manufacturing Insights: Key Investors in Latin America

Investor	Headquarter	Size	Founded	Deals 2024
	Sao Paulo, Sao Paulo, Brazil	11-50	2011	56
	Sao Paulo, Sao Paulo, Brazil	11-50	2020	5
	Las Condes, Santiago, Chile	1-10	2016	5
	Sao Paulo, Sao Paulo, Brazil	1-10	2016	1
	Sao Paulo, Sao Paulo, Brazil	11-50	2017	16
	Sunchales, Santa Fe, Argentina	51-200	2014	2
	Lo Barnechea, Santiago, Chile	11-50	2008	1
	Santiago, Santiago, Chile	1-10	2017	4
	Sabanalarga, Antioquia, Colombia	1-10	2012	0
	Las Condes, Santiago, Chile	1-10	2012	5
	Mexico City, Mexico City, Mexico	11-50	1995	0
	Sao Paulo, Sao Paulo, Brazil	11-50	2007	0
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	10
	Jardim Paulista, Sao Paulo, Brazil	11-50	2021	1
	Mexico City, Mexico City, Mexico	11-50	1999	0
	Costa Rica	1-10	2012	3
	Guatemala	1-10	2015	3

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!